Progyny Inc (PGNY)
32.60
+0.20
(+0.62%)
USD |
NASDAQ |
Apr 24, 16:00
32.60
0.00 (0.00%)
After-Hours: 20:00
Progyny Cash from Financing (TTM): -11.07M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -11.07M |
September 30, 2023 | -8.833M |
June 30, 2023 | -7.699M |
March 31, 2023 | -7.938M |
December 31, 2022 | -7.864M |
September 30, 2022 | -8.392M |
June 30, 2022 | -10.22M |
March 31, 2022 | -12.97M |
December 31, 2021 | -13.70M |
Date | Value |
---|---|
September 30, 2021 | -12.46M |
June 30, 2021 | -11.01M |
March 31, 2021 | -8.552M |
December 31, 2020 | -6.249M |
September 30, 2020 | 76.32M |
June 30, 2020 | 79.84M |
March 31, 2020 | 78.02M |
December 31, 2019 | 84.54M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-13.70M
Minimum
Dec 2021
84.54M
Maximum
Dec 2019
11.28M
Average
-8.392M
Median
Sep 2022
Cash from Financing (TTM) Benchmarks
Delcath Systems Inc | 51.78M |
Star Equity Holdings Inc | -3.072M |
Exact Sciences Corp | 159.77M |
Illumina Inc | -1.21B |
CytoSorbents Corp | 14.47M |